Home
>
US Stocks
>
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc
SNDX

Syndax Pharmaceuticals Inc (SNDX)

$16.163.58%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$16.82
Today Low/High$16.13 / $16.98
52 Week Low/High$13.02 / $25.68
P/E ratio-8.48
Market Cap$816.45M

Company Details

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the Menin-MLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor.
OrganisationSyndax Pharmaceuticals Inc
HeadquatersWaltham, Massachusetts, US
Employees43
IndustryHealth Technology
CEOBriggs Morrison

Discover more

Frequently Asked Questions

What is Syndax Pharmaceuticals Inc (SNDX) share price today?

Can Indians buy Syndax Pharmaceuticals Inc (SNDX) shares?

How can I buy Syndax Pharmaceuticals Inc (SNDX) shares from India?

Can Fractional shares of Syndax Pharmaceuticals Inc (SNDX) be purchased?

What are the documents required to start investing in Syndax Pharmaceuticals Inc (SNDX) stocks?